Advertisement
Advertisement
TMCI
Treace Medical Concepts, Inc. Common Stock
4.13
USDSponsored
-0.36
-8.02%
Jun 24, 16:00 UTC -4
Closed
After-Market
4.14
+0.01
+0.24%
TMCI Earnings Reports
Positive Surprise Ratio
TMCI beat 16 of 21 last estimates.
76%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$44.90M
/-$0.30
Implied change from Q1 26 (Revenue/ EPS)
-4.87%
/+7.14%
Implied change from Q2 25 (Revenue/ EPS)
-5.25%
/+7.14%
Treace Medical Concepts, Inc. Common Stock earnings per share and revenue
On May 08, 2026, TMCI reported earnings of -0.28 USD per share (EPS) for Q1 26, beating the estimate of -0.31 USD, resulting in a 10.88% surprise. Revenue reached 47.20 million, compared to an expected 46.88 million, with a 0.68% difference. The market reacted with a +4.69% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.30 USD, with revenue projected to reach 44.90 million USD, implying an increase of 7.14% EPS, and decrease of -4.87% in Revenue from the last quarter.
FAQ
What were Treace Medical Concepts, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Treace Medical Concepts, Inc. Common Stock reported EPS of -$0.28, beating estimates by 10.88%, and revenue of $47.20M, 0.68% above expectations.
How did the market react to Treace Medical Concepts, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 4.69%, changed from $1.92 before the earnings release to $2.01 the day after.
When is Treace Medical Concepts, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Treace Medical Concepts, Inc. Common Stock's next earnings report?
Based on 8
analysts, Treace Medical Concepts, Inc. Common Stock is expected to report EPS of -$0.30 and revenue of $44.90M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement